Bacterial Molecule Can Slow Sjögren’s Progression, Preclinical Study Suggests
Oral treatment with a molecule produced by bacteria, called colonization factor antigen I, can reduce or halt the progression of Sjögren’s syndrome, a mouse study suggests. Researchers believe these findings provide the basis for future testing in patients with Sjögren’s. The study, “Stimulation of regulatory T…